Basilea Pharmaceutica
BSLN.SW
#5986
Rank
NZ$1.96 B
Marketcap
NZ$158.15
Share price
0.14%
Change (1 day)
49.89%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2025: NZ$7.58

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is NZ$7.58. In 2025 the company made an earnings per share (EPS) of NZ$7.58 a decrease over its 2024 EPS that were of NZ$12.97.

EPS history for Basilea Pharmaceutica from 2002 to 2025

Annual EPS

Year EPS Change
2025NZ$7.58-41.53%
2024NZ$12.97586.89%
2023NZ$1.89-6.28%
2022NZ$2.02-273.94%
2021NZ-$1.16-60.87%
2020NZ-$2.96-24.46%
2019NZ-$3.92-26.92%
2018NZ-$5.3659.83%
2017NZ-$3.36-63.06%
2016NZ-$9.08-19.26%
2015NZ-$11.2546.12%
2014NZ-$7.7010.07%
2013NZ-$6.99-36.76%
2012NZ-$11.06-5.42%
2011NZ-$11.69-153.36%
2010NZ$21.91-198.47%
2009NZ-$22.25-15.34%
2008NZ-$26.2916.7%
2007NZ-$22.5236.07%
2006NZ-$16.5579.07%
2005NZ-$9.24-46.79%
2004NZ-$17.379.83%
2003NZ-$15.82-38.94%
2002NZ-$25.90